Purpose Ischemic stroke (IS) has a considerable impact on the health-related quality of life
(HRQoL) of patients. A systematic review was conducted to summarize and synthesize the …

Aim Our study aimed to explore the effectiveness and safety of intravenous t‐PA compared
with dual antiplatelet therapy (DAPT) and aspirin alone for minor stroke with National …

Background/objective This study compares the global disability status of patients who had a
mild ischaemic stroke at 30 and 90 days poststroke, as measured by the modified Rankin …

Background and Objectives IV tenecteplase is an alternative to alteplase before mechanical
thrombectomy (MT) in patients with large-vessel occlusion (LVO) ischemic stroke. Little data …

Aims Our study aimed to describe the short‐, medium‐, and long‐term outcomes of
intravenous thrombolysis in minor stroke, and to explore the relationship between …

Introduction It is unknown whether alteplase is effective and safe in patients with mild acute
ischemic stroke (AIS). Determining whether symptoms are “disabling” or not is a crucial …

Background Evaluation of outcome after stroke is largely based on assessment of gross
function 3 months after stroke onset using scales such as mRS. Cognitive or social functions …

Objective The role of endovascular mechanical thrombectomy (MT) in patients presenting
with “minor” stroke is uncertain. We aimed to compare outcomes after MT for ischemic stroke …

Background and purpose Studies have shown that mild stroke patients with National
Institutes of Health Stroke Scale (NIHSS) score 3–5 but not 0–2 may benefit from the …

Objective The distal hyperintense vessel sign (DHV) on fluid-attenuated inversion recovery
magnetic resonance image (MRI) is an imaging biomarker of slow leptomeningeal collateral …